Cloning of human neuroblastoma cells in methylcellulose culture. 1987

T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya

An in vitro methylcellulose technique was used in an attempt to culture neuroblastoma cells from 25 bone marrows from eight children with neuroblastoma. Colonies appeared within 5 days in histologically positive bone marrows. Light microscopy, linearity study, and marker study provided evidence for the neuroblastoma origin of the colonies. These colonies could be distinguished from other colonies under the inverted microscope because of its distinct feature. In one case, the characteristic morphology of neuroblastoma was shown in 3 days of culture, while histological evidence is absent. The diagnosis of neuroblastoma was confirmed by subsequent catecholamine determination. All histologically negative specimens formed no colonies, while all positive specimens formed more than three colonies. Potential application of this culturing technique for monitoring of bone marrow involvement and differential diagnosis in children with neuroblastoma is presented.

UI MeSH Term Description Entries
D008747 Methylcellulose Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative. BFL,Celevac,Cellothyl,Cellulone,Citrucel,Cologel,Dacryolarmes,Methocel,Methyl Cellulose,Muciplasma,Cellulose, Methyl
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D010751 Phosphopyruvate Hydratase A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity. Enolase,Neuron-Specific Enolase,2-Phospho-D-Glycerate Hydro-Lyase,2-Phospho-D-Glycerate Hydrolase,2-Phosphoglycerate Dehydratase,Enolase 2,Enolase 3,Muscle-Specific Enolase,Nervous System-Specific Enolase,Non-Neuronal Enolase,alpha-Enolase,beta-Enolase,gamma-Enolase,2 Phospho D Glycerate Hydro Lyase,2 Phospho D Glycerate Hydrolase,2 Phosphoglycerate Dehydratase,Dehydratase, 2-Phosphoglycerate,Enolase, Muscle-Specific,Enolase, Nervous System-Specific,Enolase, Neuron-Specific,Enolase, Non-Neuronal,Hydratase, Phosphopyruvate,Hydro-Lyase, 2-Phospho-D-Glycerate,Muscle Specific Enolase,Nervous System Specific Enolase,Neuron Specific Enolase,Non Neuronal Enolase,System-Specific Enolase, Nervous,alpha Enolase,beta Enolase,gamma Enolase
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis

Related Publications

T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
October 1980, Cancer research,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
January 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
June 1979, Biochemical and biophysical research communications,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
January 1980, Progress in clinical and biological research,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
January 1986, Anticancer research,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
February 1978, Research communications in chemical pathology and pharmacology,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
January 1989, Anticancer research,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
February 1968, Journal of pediatric surgery,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
January 1993, Anticancer research,
T Ito, and Y Ishikawa, and S Okano, and T Hattori, and R Fujii, and T Shinozawa, and A Shibuya
May 1975, Biological reviews of the Cambridge Philosophical Society,
Copied contents to your clipboard!